EGFR and head and neck squamous cell carcinoma: It has been reported that more than 90% of head and neck squamous cell carcinomas (HNSCC) overexpress epidermal growth factor receptors (EGFRs), which play an important role in tumor progression and treatment resistance and emerge as important targets for the treatment of HNSCC [4, 7].